LifeClean International (LCLEAN) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2025 was 14,788 TSEK, down from 15,857 TSEK year-over-year, mainly due to lower sales in subsidiary Kempartner Ocean AB.

• Adjusted EBITDA improved to -4,464 TSEK from -7,296 TSEK, and EBITDA to -6,051 TSEK from -11,609 TSEK, reflecting cost reductions.

• Operating loss (EBIT) narrowed to -8,292 TSEK from -13,897 TSEK year-over-year.

• Cost-saving measures and organizational restructuring contributed to improved results and operational efficiency.

• Significant commercial progress includes a two-year supply agreement in China and product launch in Europe with Arxada.

Financial highlights

• Net loss for the period was -9,168 TSEK, compared to -15,028 TSEK in Q1 2024.

• Cash flow from operating activities was -8,916 TSEK, improved from -14,430 TSEK year-over-year.

• Cash and cash equivalents at period end were 6,176 TSEK, down from 18,094 TSEK.

• Total assets decreased to 57,566 TSEK from 81,538 TSEK at the end of Q1 2024.

• Equity at period end was -12,431 TSEK, compared to 4,930 TSEK a year earlier.

Outlook and guidance

• Management expects continued growth focus, leveraging strengthened operational structure and new commercial agreements.

• The company is positioned for long-term profitable growth, with ongoing initiatives in prioritized customer segments and new markets.